Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Charmaine Kim-Sing"'
Autor:
Sara Harsini, Don Wilson, Heather Saprunoff, Hayley Allan, Martin Gleave, Larry Goldenberg, Kim N. Chi, Charmaine Kim-Sing, Scott Tyldesley, François Bénard
Publikováno v:
Cancer Imaging, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Radiotherapy (RT) and surgery are potential treatment options in patients with biochemical recurrence (BCR) following primary prostate cancer treatment. This study examines the value of prostate-specific membrane antigen (PSMA) po
Externí odkaz:
https://doaj.org/article/5f8751b6c9444577adc256ab103c63e4
Autor:
Beth Y. Karlan, Steven A. Narod, Cezary Cybulski, Charmaine Kim-Sing, Ping Sun, Rochelle Demsky, Joanne Kotsopoulos, Jan Lubinski, Nadine Tung, Jacek Gronwald, Susan Friedman, Susan L. Neuhausen, Pål Møller, Leigha Senter, Jeffrey N. Weitzel
Publikováno v:
International Journal of Cancer. 137:1136-1146
The role of the lifetime number of ovulatory cycles has not been evaluated in the context of BRCA-associated ovarian cancer. Thus we conducted a matched case-control study to evaluate the relationship between the cumulative number of ovulatory cycles
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75ec53a6d4319d57fbeaa2d8bc09d9f0
https://doi.org/10.1002/ijc.29386
https://doi.org/10.1002/ijc.29386
Autor:
Pål Møller, Jacek Gronwald, Vasily Giannakeas, Nadine Tung, Henry T. Lynch, Steven A. Narod, Jan Lubinski, Christian F. Singer, Susan L. Neuhausen, Susan Armel, Leigha Senter, William D. Foulkes, Eitan Friedman, Charmaine Kim-Sing, Ping Sun
Publikováno v:
Breast Cancer Research and Treatment. 147:113-118
Women with a genetic predisposition to breast cancer may be at increased risk of cancer after exposure to ionizing radiation. It is unclear whether mammography screening increases the risk of breast cancer among BRCA1 and BRCA2 carriers. We identifie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46dbd79443c3b8fb1826f0b38a1001ce
https://doi.org/10.1007/s10549-014-3063-y
https://doi.org/10.1007/s10549-014-3063-y
Autor:
Eitan Friedman, Peter Ainsworth, Ava Kwong, Jacek Gronwald, Sofia D. Merajver, John Lunn, Andrea Eisen, Talia Donenberg, Wendy S. Meschino, Rochelle Demsky, Taya Fallen, Fergus J. Couch, Joanne L. Blum, Albert E. Chudley, Charis Eng, Raluca N. Kurz, Kelly A. Metcalfe, Mary B. Daly, Aletta Poll, Howard M. Saal, Louise Bordeleau, André Robidoux, A Jakubowska, Steven A. Narod, Tomasz Byrski, Claudine Isaacs, Charmaine Kim-Sing, Jane McLennan, Kenneth Offit, Dominique Stoppa-Lyonnet, Nadine Tung, Robert E. Reilly, Daniel Rayson, Edmond G. Lemire, Marie E. Wood, Jan Klijn, Siranoush Manoukian, Barry P. Rosen, Gad Rennert, Gareth Evans, Susan Armel, Ruth Gershoni-Baruch, Pål Møller, Jan Lubinski, Mark E. Robson, Sonia Nanda, Beth Y. Karlan, Barbara Pasini, Henry T. Lynch, Kevin Sweet, Leigha Senter, Christian F. Singer, Ping Sun, Judy Garber, Lovise Maehle, Josephine Wagner Costalas, Ophira Ginsburg, Dawna Gilchrist, Tomasz Huzarski, Wendy McKinnon, Jeffrey N. Weitzel, William D. Foulkes, Susan L. Neuhausen, Noah D. Kauff, Christine Rappaport, Carey A. Cullinane, David M. Euhus, Tuya Pal, Dana Zakalik, Olufunmilayo I. Olopade, Seema Panchal, Cezary Cybulski, Susan T. Vadaparampil
Publikováno v:
Breast Cancer Research and Treatment. 146:421-427
Women with a mutation in BRCA1 or BRCA2 face a lifetime risk of breast cancer of approximately 80 %. Tamoxifen treatment of the first cancer has been associated with a reduction in the risk of a subsequent contralateral cancer. We studied 1,504 women
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce7b5df22a2dfdec890e6aaef924df2a
https://doi.org/10.1007/s10549-014-3026-3
https://doi.org/10.1007/s10549-014-3026-3
Autor:
T. Gregory Hislop, Kelli I. Stajduhar, Valerie Oglov, Sally Thorne, John L Oliffe, Charmaine Kim-Sing
Publikováno v:
Cancer Nursing. 36:445-453
Background: Communication in cancer care is a recognized problem for patients. Research to date has provided limited relevant knowledge toward solving this problem.Objective: Our research program aims to understand helpful and unhelpful communication
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::340ff99bb32322e7f4d30e26bb5fab4a
https://doi.org/10.1097/ncc.0b013e31827eeda4
https://doi.org/10.1097/ncc.0b013e31827eeda4
Autor:
Susan Armel, Andrea Eisen, Steven A. Narod, William D. Foulkes, Sun Ping, Nadine Tung, Ganna Chornokur, Javaid Iqbal, Jacek Gronwald, Leigha Senter, Catherine M. Phelan, Peter Möller, Jan Lubinski, Peter Ainsworth, Susan L. Neuhausen, M. Llacuachaqui, Henry T. Lynch, Christian F. Singer, Charmaine Kim-Sing, Parviz Ghadirian
Publikováno v:
British Journal of Cancer
The BRCA1 and BRCA2 genes confer increased susceptibility to breast and ovarian cancers (Wooster et al, 1995; Ford et al, 1998; Satagopan et al, 2001; Thompson et al, 2001; Antoniou et al, 2003) and to a spectrum of other cancers (Struewing et al, 19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ac7641013b34629b593c5e67e854e89
http://europepmc.org/articles/PMC3899769
http://europepmc.org/articles/PMC3899769
Publikováno v:
Clinical Genetics. 85:21-30
There is a significant variation in the uptake of cancer risk reducing options by women with a BRCA1 or BRCA2 mutation. It is currently unclear why these differences exist and it is possible that recommendations vary between providers and these influ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f899175988f7b376f21e89430faf4dd6
https://doi.org/10.1111/cge.12233
https://doi.org/10.1111/cge.12233
Autor:
Jan Lubinski, Barry P. Rosen, Susan L. Neuhausen, Beth Y. Karlan, Henry T. Lynch, Christian F. Singer, Javaid Iqbal, Jacek Gronwald, Nadine Tung, Pål Møller, Parviz Ghadirian, Leigha Senter, Yakir Segev, Sun Ping, William D. Foulkes, Steven A. Narod, Charmaine Kim-Sing
Publikováno v:
Gynecologic Oncology. 130:127-131
Objective To evaluate the risk of endometrial cancer in women who carry a mutation in the BRCA1 or the BRCA2 gene. Methods We followed 4456 women with a BRCA1 or a BRCA2 mutation for incident cases of endometrial cancer. The incidence of endometrial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdf5b84b99b340c2155f27b43a965a40
https://doi.org/10.1016/j.ygyno.2013.03.027
https://doi.org/10.1016/j.ygyno.2013.03.027
Autor:
Leigha Senter, Nadine Tung, John L. Semple, Steven A. Narod, Parviz Ghadirian, Joanne L. Blum, Susan L. Neuhausen, Tuya Pal, Donna Gilchrist, Jan Lubinski, Charmaine Kim-Sing, Ping Sun, Henry T. Lynch, Christian F. Singer, Charis Eng, Peter Ainsworth, Kelly A. Metcalfe
Publikováno v:
Annals of Surgical Oncology. 20:3817-3822
Breast reconstruction is an option for women with BRCA1 or BRCA2 mutations who elect to undergo prophylactic mastectomy to prevent breast cancer. We report on the uptake of breast reconstruction after prophylactic mastectomy in women with BRCA mutati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20aa27f9938f695b30930bfba39bfc9d
https://doi.org/10.1245/s10434-013-3040-4
https://doi.org/10.1245/s10434-013-3040-4
Publikováno v:
European Journal of Cancer Care. 22:663-672
In an ongoing longitudinal qualitative cohort study of cancer patients' needs and preferences across the cancer journey, we harvested a subset of accounts pertaining to conversations between patients and their clinicians around clinical trials. Recog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90f9811cf5c4c9426789a5a4b2c62415
https://doi.org/10.1111/ecc.12075
https://doi.org/10.1111/ecc.12075